Core Viewpoint - The company reported a decline in revenue and profit for 2024, but showed signs of recovery in Q1 2025, with a focus on both domestic and international market expansion [1][2][3]. Financial Performance - In 2024, the company achieved revenue of 10.3 billion yuan, a decrease of 9.73%, and a net profit of 1.262 billion yuan, down 36.1% [1]. - Q4 2024 revenue was 3.35 billion yuan, down 15.91%, with a net profit of 591 million yuan, down 35.1% [1]. - In Q1 2025, revenue increased to 2.478 billion yuan, up 5.42%, with a net profit of 370 million yuan, up 1.87% [1]. Business Segments - Domestic sales of medical imaging and radiation therapy equipment generated 8.445 billion yuan, a decline of 14.93%, while the service segment grew by 26.81% to 1.356 billion yuan [2]. - International revenue reached 2.266 billion yuan, an increase of 35.08%, accounting for 22% of total revenue, driven by market penetration in high-end segments [2]. R&D and Innovation - The company invested 2.261 billion yuan in R&D in 2024, representing 21.95% of revenue, and 568 million yuan in Q1 2025, accounting for 22.92% of revenue [3]. - The company has achieved significant advancements in technology across various product lines, establishing a competitive edge in the market [3]. Market Strategy - The company is focusing on a dual strategy of high-end product development and comprehensive market penetration domestically, while enhancing localized operations internationally [3]. - The global service network now covers over 85 countries and regions, supporting the operational needs of more than 34,500 devices [3].

Economic Performance - In May, China's industrial added value increased by 5.8% year-on-year, slightly below the expected 5.9% and down from 6.1% in the previous month[5] - The total retail sales of consumer goods in May grew by 6.4%, exceeding the market expectation of 5.0% and up from 5.1% in April[5] - Fixed asset investment (excluding rural households) from January to May rose by 3.7%, below the expected 3.9% and down from 4.0% in the previous month[5] - The urban surveyed unemployment rate in May was 5.0%, down from 5.1% in the previous month[5] Industrial Production - The decline in industrial production growth is attributed to external factors, with a notable drop in export delivery values, which fell by 0.3 percentage points to 0.6%[9] - Domestic demand has provided support to industrial production, with the equipment manufacturing sector's added value growing by 9%, contributing 54.3% to industrial production[13] Consumer Spending - The growth in retail sales was driven by several factors, including ongoing consumption promotion policies and the early start of e-commerce sales events[19] - Key categories such as home appliances and communication equipment saw retail sales increase by 53% and 33% respectively, contributing 1.9 percentage points to total retail sales growth[19] Investment Trends - Fixed asset investment growth has slowed, with manufacturing investment showing resilience at 7.8% year-on-year in May, despite a decline from the previous month[25] - Infrastructure investment (excluding electricity, heat, gas, and water production and supply) grew by 5.6% from January to May, down 0.2 percentage points from the previous month[29] Employment Situation - The urban surveyed unemployment rate has shown a marginal improvement, remaining at 5.0% for three consecutive months, indicating a stable employment situation[37] - However, structural pressures in the labor market persist, with the unemployment rate for migrant workers rising to 5.0%[37]

Investment Rating - The investment rating for the company is "Accumulate" (首次) [5] Core Views - The company is recognized as a national-level "little giant" in the wire and cable industry, with a projected revenue growth of 20.19% year-on-year in 2024. The main products include power cables below 500kV, which are widely used in various sectors such as power, energy, transportation, and construction [5][6] - The company is expected to achieve a revenue of 3.585 billion yuan in 2024, with a net profit of 132.92 million yuan, reflecting a year-on-year increase of 8.43% [5][6] - The demand for cables is driven by equipment renewal policies and new infrastructure plans, with the power cable business projected to grow by 22% in 2024 [5][6] Financial Summary - The company’s total market capitalization is approximately 3.297 billion yuan, with a circulating market value of about 1.913 billion yuan [3] - The company’s earnings per share (EPS) for 2025 is projected to be 0.45 yuan, with corresponding price-to-earnings (P/E) ratios of 22.4, 19.3, and 16.1 for 2025, 2026, and 2027 respectively [6][7] - The company is expected to maintain a gross margin of 10.86% and a net margin of 3.71% in 2024 [5][7] Market Position and Strategy - The company aims to enhance its market position by focusing on high-voltage and special cables, while also expanding its presence in the new energy cable sector [5][6] - The company has established a strong customer base, with the State Grid Corporation and China Southern Power Grid being the largest clients, accounting for 63% of total sales [5][6] - The company plans to continue strengthening its market share in the local power sector and expand into large state-owned enterprises and foreign trade markets [6]

Group 1 - Company achieved total operating revenue of 1,030,010.44 million yuan in 2024, a year-on-year decrease of 9.73% [2] - Net profit attributable to shareholders of the listed company was 126,186.95 million yuan, down 36.08% year-on-year [2] - The decline in revenue is primarily due to the impact of domestic equipment update policy implementation, leading to an overall contraction in the industry [2] Group 2 - Company has increased R&D investment, with no significant changes in core competitiveness [2][4] - Company has applied for a total of 11,502 intellectual property rights and has obtained 5,882 [2][4] - There were no violations found in the use of raised funds, and there were no significant changes in the holdings of controlling shareholders and executives during the reporting period [2]

Group 1: Economic Performance - In April, China's industrial added value increased by 6.1% year-on-year, exceeding the expected 5.2% and down from 7.7% in the previous month[5] - The retail sales of consumer goods in April grew by 5.1% year-on-year, slightly below the expected 5.5% and down from 5.9% in March[5] - Fixed asset investment (excluding rural households) from January to April rose by 4.0% year-on-year, below the expected 4.3% and down from 4.2% in the previous period[5] Group 2: Sector Analysis - The manufacturing sector showed resilience, with April's manufacturing investment growth at 8.2% year-on-year, despite a 0.9 percentage point decline from the previous month[26] - Infrastructure investment (excluding electricity, heat, gas, and water production and supply) grew by 5.8% year-on-year from January to April, consistent with the first quarter[28] - Real estate development investment recorded a year-on-year decline of 11.3% in April, continuing a downward trend[30] Group 3: Employment Trends - The urban surveyed unemployment rate in April was 5.1%, down from 5.2% in March, indicating a seasonal decline[32] - The unemployment rate for local registered labor was 5.2%, while for migrant workers it was 4.8%, both showing a decrease from previous values[32]

Economic Overview - In April, industrial and service sector weighted year-on-year growth was 6.1%, down from 6.8% in March but higher than the 5.7% in January-February[1] - April's export delivery value increased by only 0.9% year-on-year, a significant slowdown from March's 7.7%[2] - Retail sales grew by 5.1% year-on-year in April, a decrease of 0.8 percentage points from March, but still above 5%[4] Trade and Investment Insights - The contribution of export delivery value to industrial revenue dropped to approximately 0.1%, down from 0.8% in March, indicating a significant decline in export-driven growth[2] - Fixed asset investment in April showed a year-on-year growth of 3.5%, with manufacturing investment slowing from 9.2% in March to 8.2% in April[3][6] - Equipment and tool purchases accounted for 64.5% of total investment growth, with a year-on-year increase of 18.2% from January to April[6] Real Estate Market Trends - Real estate sales in April saw a year-on-year decline of 2.1% in sales area and 6.7% in sales value, indicating a slowdown in the housing market[7] - The average price of new homes in April declined, with second-hand housing prices in 70 cities dropping by 0.4% month-on-month[7][8] - Financing for real estate development decreased by 4.1% year-on-year from January to April, reflecting a decline in pre-sale deposits and personal mortgage loans[7] Future Outlook - The potential for a new round of export growth is anticipated due to tariff reductions between the U.S. and China, which may lead to a surge in exports from mid-May to August[8] - Domestic policy adjustments may be delayed until August-September, with a focus on monetary easing as the economy stabilizes[9] - The stock market may experience narrow fluctuations, with a need for clear signals of fundamental recovery to drive further strength[9]

Core Insights - The spokesperson of the National Bureau of Statistics, Fu Linghui, stated that from January to April, China's equipment investment increased by 18.2% year-on-year, contributing 64.5% to the overall investment growth [1] Investment Growth - Equipment purchase investment in China saw a significant year-on-year increase of 18.2% during the first four months of the year [1] - The contribution rate of equipment investment to total investment growth reached 64.5%, indicating its critical role in driving overall investment [1]

Investment Rating - The report assigns a "Buy" rating to the company with a target price of 25.90 CNY for the next six months, based on a current price of 20.95 CNY [1]. Core Insights - The company has turned profitable, with significant growth potential driven by domestic substitution and equipment upgrade policies. The report forecasts substantial increases in revenue and net profit over the next few years [6][24]. Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 3.61359 billion CNY, a year-on-year increase of 13.6%. The net profit attributable to the parent company was 206.86 million CNY, up 164.1% from the previous year. For Q1 2025, revenue was 550 million CNY, a 1.4% increase year-on-year, while the net profit was a loss of 21 million CNY, showing a reduction in losses compared to the previous year [6][14]. Business Model and Strategy - The company is a leader in high-end analytical instruments in China, focusing on core instrument business while reducing non-profitable segments. It has developed a "4+X" multi-business model covering various sectors including smart industry, smart environment, smart laboratory, and life sciences [7][12]. Profitability and Efficiency - The gross margins for the company's core instrument, operation services, and environmental governance businesses were 48.5%, 38.0%, and 27.3% respectively in 2024, showing improvements year-on-year. The company has implemented cost reduction and efficiency enhancement measures, leading to a significant decrease in expense ratios [6][17][19]. Earnings Forecast - The report projects net profits for 2025, 2026, and 2027 to be 332.24 million CNY, 413.02 million CNY, and 485.35 million CNY respectively, with corresponding EPS of 0.74 CNY, 0.92 CNY, and 1.08 CNY [24][26]. Valuation - The company is valued at a PE ratio of 35 times for 2025, which is lower than the average PE of comparable companies at 40.5 times. This reflects the company's potential to benefit from domestic substitution and equipment upgrade policies [24][27].

Group 1: Investor Relations Activity Overview - The investor relations activity was conducted online on May 7, 2025, with participation from various securities and asset management firms [3][4] - Key attendees included the Chairman and the Board Secretary of the company [4] Group 2: Company Performance and Market Impact - The company's performance in Q1 2025 showed recovery, influenced by national policies promoting equipment updates, which are more concrete compared to 2018 [5] - The ongoing equipment updates in universities and government agencies are expected to positively impact the company in the second half of the year [5] Group 3: Product-Specific Insights - The revenue from the organic element analysis product decreased by over 22% in 2024, primarily due to the completion of the third national soil survey and reduced demand for equipment updates in universities [6] - The company is launching a platform for the Soxhlet extraction instrument to expand applications in ecological agriculture, semiconductors, and new materials [7] - The new generation of fully automatic Kjeldahl nitrogen analyzers features higher automation and efficiency, targeting high-end market demands [8] Group 4: Market Position and Competitive Landscape - The liquid chromatography market is dominated by imported brands, holding over 90% market share, while the company's subsidiary is in the market introduction phase [9] - The advantages of the subsidiary's liquid chromatography products include high starting points in development, leading quality control, and self-controlled core technologies [9] - The newly launched fully automatic laboratory cleaning machine has significant market potential, with low current penetration and high overlap with existing product users [10] - The expected gross margin for the laboratory cleaning machine is anticipated to be at a higher level within the industry due to the company's manufacturing advantages [10]

Investment Rating - The investment rating for the company is maintained at "Buy" with a target price of RMB 328.30 [7][8]. Core Views - The company reported a revenue of RMB 367.26 billion and a net profit attributable to the parent company of RMB 116.68 billion for 2024, reflecting a year-on-year growth of 5.1% and 0.7% respectively. The profit was below market expectations due to delays in domestic equipment upgrade policies [1]. - The company is expected to achieve steady growth in 2025, driven by the acceleration of domestic equipment upgrade policies and ongoing efforts in product promotion both domestically and internationally [1]. - The company’s three core business segments are projected to perform well in 2025: 1. IVD segment revenue reached RMB 137.65 billion in 2024, with a year-on-year increase of 10.8% and strong overseas growth [2]. 2. Medical imaging segment revenue was RMB 74.98 billion, up 6.6% year-on-year, supported by the launch of high-end products [2]. 3. Life information and support segment revenue was RMB 135.57 billion, down 11.1% year-on-year, but expected to rebound in 2025 due to improving domestic policies [2]. Summary by Sections Financial Performance - The company’s revenue for 1Q25 was RMB 82.37 billion, with a net profit of RMB 26.29 billion, showing a year-on-year decline of 12.1% and 16.8% respectively, but a quarter-on-quarter increase of 13.8% and 154.9% [1]. - The company’s revenue forecast for 2025 is RMB 40.545 billion, with a projected net profit of RMB 12.84 billion, reflecting a growth of 10.04% [6]. Market Expansion - The company’s overseas revenue reached RMB 164.34 billion in 2024, growing by 21.3%, with significant contributions from the Asia-Pacific and European regions [3]. - Domestic revenue was RMB 202.92 billion, down 5.1% year-on-year, but expected to improve in 2025 due to the release of medical infrastructure orders and enhanced competitiveness [3]. Profitability and Valuation - The EPS forecast for 2025 is adjusted to RMB 10.59, with a PE ratio of 31x for 2025, leading to a target price of RMB 328.30 [4]. - The company is recognized as a leading domestic medical device manufacturer with strong brand influence and a continuously improving global sales network [4].